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SUMMARY
Cryptosporidium isolates identified in fourteen stool samples, collected from five HIV-infected patients and nine
immunocompetent children, living in the Sate of São Paulo, Brazil, were submitted to a molecular analysis using a nested PCR
followed of restriction fragment length polymorphism (RFLP), for genetic characterization. The analysis was based on digestion
with RsaI restriction enzyme of a DNA fragment amplified from the Cryptosporidium oocyst wall protein (COWP) gene. Based on
this analysis, four samples were identified as Cryptosporidium parvum, eight as Cryptosporidium hominis and two presented a
profile that corresponded to Cryptosporidium meleagridis when compared to the standards used in the analysis. The use of molecular
methods can be helpful to identify source of infections and risk factors related to Cryptosporidium infection in our communities.
KEYWORDS: Cryptosporidiosis; PCR; Genotyping; Cryptosporidium parvum; Cryptosporidium hominis; Cryptosporidium
meleagridis; Brazil.
INTRODUCTION
Nearly 100 years after description of the first Cryptosporidium
species, in mice by Tyzzer, it is known that Cryptosporidium spp. can
occur in distinct classes of vertebrates, such as fishes, reptiles,
amphibians, birds and mammals12,20,27,28.
In humans, infection by Cryptosporidium sp. was first registered
in 1976, and Cryptosporidium parvum (previously known as cattle
genotype or genotype 2) and Cryptosporidium hominis (previously
known as C. parvum - human genotype or genotype 1) have been
recorded as the two species most frequent cause of human
cryptosporidiosis, either associated with sporadic cases of infections
or outbreaks, some of them being very large as the one that occurred
in Milwaukee WI, USA, which affected approximately 400,000
persons12,17. To date, all the cryptosporidiosis outbreaks occurring
worldwide have been caused by C. hominis and C. parvum, with several
being associated with consumption of drinking water or exposure to
recreational water contaminated with Cryptosporidium oocysts of
zoonotic and anthroponotic origins15,27,30. Due to the size and frequency
of these outbreaks, cryptosporidiosis became a serious public health
issue worldwide and prompted reevaluation of the microbiological
standards for drinking water by health authorities in developed and
developing countries. In countries like Brazil, it is mandatory that
potable water be also free of Cryptosporidium sp. and Giardia sp.3.
Although all outbreaks studied to date have been associated with the
two species of Cryptosporidium listed above, it is also known that at least
some zoonotic species, such as Cryptosporidium canis, Cryptosporidium
felis, and Cryptosporidium meleagridis, can indeed infect both
immunocompromised and immunocompetent persons4,14,18,21,22,24.
In different regions of Brazil, including São Paulo, studies involving
patients with compromised immune systems either HIV-positive or
not, and children, with or without diarrhea, have shown different rates
for presence of Cryptosporidium spp. in their stools5,7,8,15,19,25.
Serological surveys conducted in Brazil showed the presence of anti-
Cryptosporidium antibodies in a large number of children living in
slums of the northeastern region of Fortaleza, state of Ceara1, and also
in individuals with no intestinal symptoms living in the state of São
Paulo. In this last study the frequencies for anti-Cryptosporidium
antibodies varied from 10% to 80%, according to the age group9.
Environmental contamination with Cryptosporidium was also reported
in rivers and other public water sources11,13. Despite the great number
of reports about occurrence of Cryptosporidium infection in Brazil,
only few studies addressed the molecular characterization of the isolates
found in the studied clinical specimens. In one of the studies carried
out in the northeast region, two isolates were identified as C. parvum,
one as C. hominis, but the authors were not able to genetically
characterized one of the isolates2. Other study identified seven Brazilian
children infected with C. hominis14 and another revealed the presence
of a single genotype of C. hominis based on analysis of three genes in
29 samples from a diarrhea outbreak investigated in a day care in São
Paulo, SP15.
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In the present study, a nested PCR followed by RFLP, of a fragment
of the Cryptosporidium oocyst wall protein (COWP) gene, was used
to identify the species of Cryptosporidium isolates from HIV-infected
patients and immunocompetent children living in the Sate of São Paulo,
Brazil.
MATERIAL AND METHODS
Cryptosporidium isolates. A total of 14 stool samples, positive for
Cryptosporidium sp. by microscopic examination of stools, were
obtained from adults and children, with or without diarrhea, living in
three cities of the State of Sao Paulo, Brazil. Five samples (SO32,
SO49, SO507, SO623 and SO689) were obtained from HIV-infected
patients submitted to diagnostic testing at the Public Health Laboratory
of Sorocaba city; five samples (SP06, SP07, SP12, SP17 and SP31)
were obtained from children living in a slum located in the city of São
Paulo and submitted for testing by the Parasitology Laboratory of the
Albert Einstein Hospital; and four samples (TT01, TT03, TT06 and
TT07) were selected during an active laboratory survey focusing on
identification of cases of cryptosporidiosis in day care center from the
city of Taubate, São Paulo State. The aspect of the children’s stool
samples varied from formed (n = 6) to loose-diarrheic (n = 3) and they
were included in the study after identification of Cryptosporidium
oocysts by Kinyoun staining method or detection of Cryptosporidium
antigens by ELISA test on micro plate (ProSpecT - Alexon Inc.). The
study protocol was approved by the Research Ethical Committee of
the University of Taubate.
DNA extraction. DNA was extracted from stool samples using
the FastDNA® method (MP Biomedicals, Solon, OH), as previously
described10 with the exception that the samples were disrupted using
vortex mixer, instead of the FP120 FastPrep cell disrupter. For
disruption, samples were agitated by vortexing during one minute three
consecutive times. The extracted DNA was further purified with the
QIAquick PCR purification kit (Qiagen, Inc., Santa Clarita, CA),
according to manufacturer’s instructions, for complete removing of
the PCR inhibitors10, and then stored at -20 ºC.
Amplification of fragments from the COWP gene. Nested-PCR
was carried out using the protocol described by PEDRAZA-DIAZ et
al.23: in the first step amplification, primers BCOWPF (ACC GCT TCT
CAA CAA CCA TCT TGT CCT C) and BCOWPR (CGC ACC TGT
TCC CAC TCA ATG TAA ACC C) were used to produce a fragment of
769-bp; in the secondary PCR, primers Cry15 (GTA GAT AAT GGA
AGA GAT TGT G) and Cry9 (GGA CTG AAA TAC AGG CAT TAT
CTT G), described by SPANO et al.26, were used to amplify a DNA
fragment of 553-bp. PCR reactions were performed in a total volume
of 25 µL containing 2.5 µL of the DNA template in 1x PCR buffer, 1.5
mM MgCl
2
, 0.25 mM of each dNTP (Amersham Bioscences), 10
pmoles of each primer, and 1.25 units of Taq DNA polymerase
(Invitrogen, Brazil). Cycling conditions used were: initial denaturation
cycle of 94 ºC for five minutes, followed by 30 cycles of 65 ºC for one
minute, 72 ºC for one minute and 94 ºC for one minute; and a final
extension at 72 ºC for 10 minutes, which were carried out in a
Mastercycle Gradient (Eppendorf, Hamburg, Germany). 2.5 µL of the
products of the primary PCR were amplified with Cry15/Cry9 primers
using the same volumes, concentrations of reagents and themocycler
listed above. Cycling conditions for the nested PCR were: initial
denaturation of 94 ºC for five minutes, followed by 30 cycles of 55 ºC
for 30 seconds, 72 ºC for 50 seconds and 94 º C for 50 seconds, and a
final extension at 72 ºC for 10 minutes. The PCR products were analyzed
by electrophoresis on 1.5% agarose gel, stained with ethidium bromide,
visualized on an ultraviolet transilluminator, and then digitalized
(Digital Kodak Science 1DTM).
RFLP analysis. An aliquot of 5 µL of each nested-PCR product
was subjected to digestion with RsaI restriction enzyme (Amersham
Biosciences), for 12 hs at 37 ºC, according to manufacturer´s protocol.
Restriction products were separated through electrophoresis on a 3.0%
agarose gel, visualized by staining with ethidium bromide, followed
by ultraviolet transillumination, and then digitalized (Digital Kodak
Science 1DTM). Size markers included in all gels were 100bp DNA
Ladder (Invitrogen, Brazil). The RFLP patterns of different
Cryptosporidium isolates were compared to the sequences available in
the GenBank.
RESULTS
Amplicons with the expected size were generated from 14 isolates
using the COWP Nested-PCR. In order to characterize these
amplicons, we used a standard RFLP protocol with RsaI restriction
enzyme. Three distinct RFLP patterns were obtained, which indicated
the presence of C. parvum, C. hominis, and C. meleagridis based on
patterns that could be obtained with COWP gene sequences for these
three species available in GenBank. Eight isolates revealed fragments
of 284, 129, 106 and 34-bp which would indicate the presence of C.
hominis, based on RsaI RFLP patterns with GenBAnk accession
numbers: AF248741; AJ849458; AJ849459; AY282691; AJ971799;
AJ971800 and AJ971801. Fragments of 413, 106 and 34-bp were
obtained from four samples, and these were related to C. parvum
based on the same rationale using GenBank accession numbers:
AB89292; AF248743; AF266265; AF266273; AY277701; and
Z22537. Fragments of 372, 147 and 34-bp were obtained from two
samples, which would indicate the presence of C. meleagridis, based
on GenBank accession numbers: AF248742; AF266266; AJ971802;
AY166840; AY282694 and DQ116568. The distribution of the 14
Cryptosporidium isolates according to the identified species and the
city of origin, Taubaté (TT), Sorocaba (SO) and São Paulo (SP), was
presented in the Table 1. Representation of the sites of cleavage
(GT↓AC) found in the Cry15/Cry9 amplicons is showed in Fig. 1. A
representative gel showing RFLP profiles of three genetic groups,
detected in this study, is shown in Fig. 2.
DISCUSSION
The relevance of Cryptosporidium sp. as a causative agent of severe
and chronic diarrhea, representing an important cause of morbidity
and mortality among malnourished children and immunocompromised
patients, such as those infected with HIV or submitted to organ
transplants8,25,28, has been extensively discussed in the literature.
However, the prevalence of this parasite in immunocompetent children
is not well known. The morphologic diagnosis of this parasite is a
challenge for microscopist unless they are very well trained in
recognizing Cryptosporidium sp. oocysts in stool samples. This is
enhanced by the fact that not all clinical laboratories in Brazil perform
special staining techniques, eg, modified acid-fast recommended for
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the detection of Cryptosporidium sp. oocysts16. Also, in Brazil, it is
not a practice among the pediatricians to request a specific laboratory
diagnostic test for cryptosporidiosis in cases of diarrhea illness.
Among the 16 currently accepted species of Cryptosporidium27, C.
hominis and C. parvum are the most frequently associated to human
infections. However, zoonotic species, such as C. meleagridis, C. felis,
and C. canis, and also other genotypes of C. parvum, adapted to varied
animal species, have been isolated from patients with cryptosporidiosis
and identified by molecular methods18,21,22,24,29,30. These findings bring
up evidences that different species of Cryptosporidium can circulate
in the environment, being potential pathogens for humans and animals;
this justify the use of molecular techniques for characterization of
Cryptosporidium at species level, for better understanding the
epidemiology of cryptosporidiosis in specific areas.
The occurrence of the Cryptosporidium anthroponotic and the
zoonotic transmission cycles overlapping in the same area enhances
the exposure of human beings to this parasite, especially in areas with
inadequate sanitary infrastructure. Consequently, contaminated water
and foods can be important vehicles for transmission of
cryptosporidiosis12. For obvious reasons, special attention must be given
to water, considering that Cryptosporidium oocysts are resistant to
chlorination. Thus, efforts to improve detection and identification of
the parasite as well as disinfection of drinking and recreational water
have been the focus of many public health programs worldwide.
Nowadays it is important that the diagnosis of cryptosporidiosis must
be carried out not only by morphologic criteria, but also by molecular
techniques to allow accurate identification of Cryptosporidium at
species level. Several species of this genus are morphologically
indistinguishable and only microscopic examination is not enough for
species identification in clinical or environment samples.
In the present study, the use of molecular tools allowed the
identification of three different species of Cryptosporidium, i.e., C.
hominis, C. parvum and C. meleagridis, the later being identified only
in two HIV-infected patients. It is known that this species naturally
infect different species of birds, and in humans it is more frequently
described in HIV-infected patients, although different authors have
identified cases of C. meleagridis infection not restricted to
immunocompromised individuals6,22,29. Among the nine
immunocompetent children studied, six cases were associated with
infection by C. hominis and three cases by C. parvum. Although the
number of samples studied was not large, the observation that more
infections with C. hominis than C. parvum were detected may indicate
the predominance of the anthroponotic cycle in the studied areas. This
situation was more evident among the children living in a slum of the
São Paulo City, where four samples were positive for C. hominis and
Table 1
Cryptosporidium isolates according to the identified species and the city of source for stool samples
City of source for Cryptosporidium species Total number
stool samples C. hominis C. parvum C. meleagridis of isolates
Sorocaba 2 (a) 1 (b) 2 (c) 5
São Paulo 4 (d) 1 (e) - 5
Taubaté 2 (f) 2 (g) - 4
Total 8 4 2 14
(a) samples SO322, SO507; (b) sample SO49; (c) samples SO623 and SO689; (d) samples SP06, SP07, SP17, SP31; (e) sample SP12; (f) samples TT03 and TT06; (g) samples
TT01 and TT07.
Fig. 2 - Restriction patterns of the COWP gene nested-PCR products of 553 bp, amplified
with the primers Cry15/Cry9, from two Cryptosporidium isolates from Taubate (TT), four
from Sorocaba (SO), and five from Sao Paulo (SP). 100-bp Ladder DNA (lane 1); undigested
Cry15-Cry9 amplicon (lane 2); C. meleagridis: SO689 (lane 3), SO623 (lane 5); C. hominis:
SP31 (lane 4), TT03 (lane 7), SP06 (lane 8), SP07 (lane 9), SO322 (lane 11), SP17 (lane 12),
and SO507 (lane 13); C. parvum: TT07 (lane 6) and SP12 (lane 10).
Fig. 1 - Representation of the fragments produced by digestion with RsaI on COWP gene,
generated after nested PCR with primers Cry15/Cry9, from C. hominis, C. parvum, and C.
meleagridis. The numbers above the line represent the nucleotide positions where RsaI
cleavage sites are located, and the numbers below represent the size of the restriction fragments
produced in each species.
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only one was positive for C. parvum. It is also interesting to notice the
identification of two cases of C. parvum and two of C. hominis among
the day care children in Taubaté City. It can suggest a possible
occurrence of person-to-person transmission of some zoonotic species,
after its introduction into confined environments, such as day-care-
centers, home-care and hospital settings; and then, it might be able to
present an anthroponotic standard of transmission, with a significant
epidemiological implication on public health. The use of molecular
tools in studies such as the one presented here will allow better
characterization of Cryptosporidium species, which is helpful to identify
the source of infections and risk factors, and to allow the control of
cryptosporidiosis in our communities.
RESUMO
Identificação genotípica de Cryptosporidium spp. isolados a
partir de pacientes com HIV e crianças imunocompetentes de
São Paulo, Brasil
Isolados de Cryptosporidium identificados em quatorze amostras
de fezes, coletadas de cinco pacientes com infecção por HIV e de nove
crianças imunocompetentes, residentes no estado de São Paulo, Brasil,
foram submetidos a análise molecular por Nested-PCR, seguido da
caracterização genética por polimorfismo do tamanho do fragmento
de restrição (RFLP). A análise foi baseada na digestão, com a enzima
de restrição RsaI, de um fragmento de DNA amplificado do gene que
codifica a proteína de parede do oocisto de Cryptosporidium (COWP).
Baseado nesta análise, quando comparado aos padrões utilizados, quatro
amostras foram identificadas como Cryptosporidium parvum, oito como
Cryptosporidium hominis e duas apresentaram um perfil correspondente
ao de Cryptosporidium meleagridis. O uso de métodos moleculares
pode ser útil para identificar a fonte das infecções e os fatores de risco
relacionados à infecção por Cryptosporidium em nossas comunidades.
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